Home
>
National Drug Code (NDC)
>
Boniva
Boniva - 0004-0191-09 - (ibandronate sodium)
Drug Information of Boniva
| Product NDC: | 0004-0191 |
| Proprietary Name: | Boniva |
| Non Proprietary Name: | ibandronate sodium |
| Active Ingredient(s): | 3 mg/3mL & nbsp; ibandronate sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Boniva
| Product NDC: | 0004-0191 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021858 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110601 |
Package Information of Boniva
| Package NDC: | 0004-0191-09 |
| Package Description: | 1 SYRINGE, GLASS in 1 CARTON (0004-0191-09) > 3 mL in 1 SYRINGE, GLASS |
NDC Information of Boniva
| NDC Code | 0004-0191-09 |
| Proprietary Name | Boniva |
| Package Description | 1 SYRINGE, GLASS in 1 CARTON (0004-0191-09) > 3 mL in 1 SYRINGE, GLASS |
| Product NDC | 0004-0191 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ibandronate sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110601 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | IBANDRONATE SODIUM |
| Strength Number | 3 |
| Strength Unit | mg/3mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
